THU195 6-Month Subcutaneous Leuprolide Acetate Achieved And Maintained Hormonal And Clinical Suppression In All Weight Groups Of Children With Central Precocious Puberty

por Miller, Bradley S, Boldt-Houle, Deborah, Atkinson, Stuart N
Publicado 2023

ODP397 Small-volume, Subcutaneous, 6-month Leuprolide Acetate Effectively Reduces Growth Velocity to Prepubertal Levels in Children with Central Precocious Puberty

por Klein, Karen O, Atkinson, Stuart N, Boldt-Houle, Deborah M
Publicado 2022

6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children With Central Precocious Puberty

por Eugster, Erica A, Atkinson, Stuart, Boldt-Houle, Deborah, Miller, Bradley Scott
Publicado 2021

Subcutaneous in situ gel delivered leuprolide acetate's consistent and prolonged drug delivery maintains effective testosterone suppression independent of age and weight in men wit...

por Renzulli, Joseph F., Tagawa, Scott T., Atkinson, Stuart N., Boldt‐Houle, Deborah M., Moul, Judd W.
Publicado 2020